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Diphtheria is an acute and highly infectious disease, previously regarded as endemic
in nature but vaccine-preventable, is caused by Corynebacterium diphtheriae (Cd). In
this work, we used an in silico approach along the 13 complete genome sequences
of C. diphtheriae followed by a computational assessment of structural information
of the binding sites to characterize the “pocketome druggability.” To this end, we
first computed the “modelome” (3D structures of a complete genome) of a randomly
selected reference strain Cd NCTC13129; that had 13,763 open reading frames
(ORFs) and resulted in 1,253 (∼9%) structure models. The amino acid sequences
of these modeled structures were compared with the remaining 12 genomes and
consequently, 438 conserved protein sequences were obtained. The RCSB-PDB
database was consulted to check the template structures for these conserved proteins
and as a result, 401 adequate 3D models were obtained. We subsequently predicted
the protein pockets for the obtained set of models and kept only the conserved
pockets that had highly druggable (HD) values (137 across all strains). Later, an
off-target host homology analyses was performed considering the human proteome
using NCBI database. Furthermore, the gene essentiality analysis was carried out
that gave a final set of 10-conserved targets possessing highly druggable protein
pockets. To check the target identification robustness of the pipeline used in this
work, we crosschecked the final target list with another in-house target identification
approach for C. diphtheriae thereby obtaining three common targets, these were;
hisE-phosphoribosyl-ATP pyrophosphatase, glpX-fructose 1,6-bisphosphatase II, and
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rpsH-30S ribosomal protein S8. Our predicted results suggest that the in silico approach
used could potentially aid in experimental polypharmacological target determination in
C. diphtheriae and other pathogens, thereby, might complement the existing and new
drug-discovery pipelines.
Keywords: Corynebacterium diphtheria, pocketome, druggable genome, structural proteomics, putative
therapeutic targets, highly druggable (HD), global druggable (GD)
INTRODUCTION
Corynebacterium diphtheriae belong to the class Actinomycetales
and is a Gram-positive bacterium, a non-spore forming, non-
motile and facultative anaerobe with pleomorphic cell shape
and high GC content (∼53%) relative to the Firmicutes
(Cerdeno-Tarraga et al., 2003; Trost et al., 2012). This
bacterium is the causative agent of diphtheria, a severe human
respiratory manifestation characterized by bacterial adhesion
to host pharyngeal cell (pharyngitis and pseudomembranous
inflammation). The pathogen target one or both tonsils
that further disseminate at a later stage thereby resulting
in complete airway obstruction and death (Hadfield et al.,
2000). The cornerstone in diphtheria therapy involves the
hyper immune antiserum-antitoxin produced in equines that
neutralizes the C. diphtheriae toxin while among antibiotics are
the broad-spectrum penicillin or erythromycin. However, recent
emergence of numerous drug-resistant strains subsequently
decreases the efficacy of current therapeutics (Barraud et al.,
2011). Importantly, the World Health Organization recommends
widespread DTPs immunization against toxigenic diphtheria
strains as the only effective approach to counteract the infection.
Although, a slight change in mortality has been observed since
the availability and administration of antibiotics, specifically
penicillin or erythromycin (Adler et al., 2013). C. diphtheriae
has four biotypes: gravis, mitis, intermedius and belfanti that are
non-sporulating, unencapsulated, non-motile and pleomorphic
bacilli. They are subsequently classified on the basis of differences
in colonial morphology, haemolytic potential, fermentation
reactions and severity of the resulting disease (Gerald et al.,
2009; Brooks et al., 2010). The infant mortality rate in an
epidemic that resulted in thousands of casualties dropped
gradually in countries where living standards were improved
and immunization programs were introduced. Nevertheless, it
still remains a significant pathogen around the globe (Hodes,
1979). The ‘strangling angel’ effects on children that scaled from
wing-shaped disarticulation and pseudo-membranes formation
in the oropharynx, triggered acute obstruction of airways and
resulted in mortalities (Hodes, 1979; Hart et al., 1996; Jamal
et al., 2017b). A plethora of cases were recently reported and still
expected from both non-lethal and lethal diphtheria in different
parts of the world due to significant population displacements
via immigration. An adequate supervision necessitates quick
measures to discover additional diphtheria antitoxin, antibiotic
and therapeutic treatment (Pizza et al., 2000).
The emerging concepts of polypharmacology, differential
genome analyses, and reverse vaccinology, comparative and
subtractive microbial genomics have largely contributed by
establishing complementary traditions for fast identification of
novel targets in post-genomic era (Perumal et al., 2007; Barh
et al., 2013). Comparative homology modeling (Baumbach, 2010;
Rottger et al., 2013) has widely been used in expanding the
structural space of pathogens (Chong et al., 2006; Asif et al.,
2009).
These practices are being used for the identification of
conserved targets in a several human and animal pathogens
like C. tuberculosis (Hassan et al., 2014; Radusky et al., 2015),
Mycobacterium. tuberculosis (Asif et al., 2009), Burkholderia
pseudomallei (Chong et al., 2006), Neisseria gonorrhoea (Barh
and Kumar, 2009), Helicobacter pylori (Dutta et al., 2006),
Pseudomonas aeruginosa (Sakharkar et al., 2004; Perumal et al.,
2007), and Salmonella typhi (Rathi et al., 2009).
In this work, a combination of in silico tools was primarily
used to predict the core proteome of C. diphtheriae species to
associate genomic information based on the 3D structures. The
predicted proteomes were modeled (pan-modelome) using a
methodology adapted by Hassan et al. (2014). From a structural
point of view, druggability is the probability of small drug-like
molecules binding to a given target protein with high affinity
(<1 µM). We report for the first time the structural druggability
assessment for multi-strain C. diphtheriae proteomes using a
pan-druggability prediction pipeline based on the open source
pocket detection code “fpocket”. The method integrates several
physicochemical descriptors to estimate the pocket druggability
on a genomic scale with suitable features that enable binding of a
drug-like compound (Kinnings et al., 2010).
MATERIALS AND METHODS
Initial Dataset Construction
All ORFs (Open Reading Frames) of the 13 completely sequenced
genomes of C. diphtheriae were obtained from the NCBI
database1. Table 1 shows the statistical data of all strains used in
this study where the strain NCTC13129 has 2,272 reported ORFs
and was randomly selected as a reference genome for modelome
prediction and further analyses.
General Concept: Modelome Prediction
The binding affinity of small drug-like molecules to the
active site of putative biological targets (druggable protein
cavities) formulated a basis for this work, a slightly modified
protocol of Radusky et al. (2015) (Figure 1). All genome ORF
sequences of the 13 C. diphtheriae strains were subjected to
1https://www.ncbi.nlm.nih.gov/genome/genomes/1025?
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TABLE 1 | Summary of Corynebacterium diphtheriae strains used in this study and their respective modeling statistics for druggability analyses.
Strain Biovar Location NCBI accession Genome size (Mb) GC% Proteins Models – G2
31A N/A Brazil NC_016799.1 2.53535 53.60 2380 1283
241 N/A Brazil NC_016782.1 2.42655 53.40 2245 1235
BH8 N/A Brazil NC_016800.1 2.48552 53.60 2361 1269
C7 N/A United States NC_016801.1 2.49919 53.50 2337 1278
CDCE8392 Mitis United States NC_016785.1 2.43333 53.60 2249 1253
HC01 Mitis Brazil NC_016786.1 2.42715 53.40 2247 1236
HC02 Mitis Brazil NC_016802.1 2.46861 53.70 2230 1254
HC03 Mitis Brazil NC_016787.1 2.47836 53.50 2262 1260
HC04 Gravis Brazil NC_016788.1 2.48433 53.50 2275 1260
INCA402 Belfanti Brazil NC_016783.1 2.44907 53.70 2214 1282
PW8 N/A United States NC_016789.1 2.53068 53.50 2414 1272
VA01 Gravis Brazil NC_016790.1 2.39544 53.40 2191 1239
NCTC13129 Gravis United Kingdom NC_002935.2 2.48863 53.50 2272 1253
the MHOLline workflow2 in.faa file format for 3D structure
prediction. MHOLline utilizes multi fasta files of amino acids
as an input data and then uses HMMTOP, BLAST, BATS,
Modeller and Procheck programs for the detailed analyses. The
program HMMTOP detects transmembrane regions. The BLAST
algorithm is used to identify template structure by performing
a random search against the Protein Data Bank. BATS (Blast
Automatic Targeting for Structures) carry out the refinement in
the template search; it is a key step for the model construction.
BATS refinement identifies sequences that make the modeling
possible by selecting a template from BLAST output file using
their BATS scores, expectation values, identity and sequence
similarity as criteria as well as considering the number of gaps
and the alignment coverage. BATS select the best template for
3D model generation and perform automated alignment used by
the MODELLER program. Furthermore, it gathers all the BLAST
output files into four distinctive groups, i.e., G0, G1, G2, and G3,
according to the following criteria; G0 = Not aligned sequence,
G1 = E-value > 10e−5 or Identity < 15%, G2 = E-value ≤ 10e−5
and Identity ≥ 25% AND LVI ≤ 0.7, G3 = E-value ≤ 10e−5
and Identity ≤ 15% and <25% OR LVI > 0.7, Where LVI is
the Length Variation Index, a MHOLline concept of coverage
(LVI≤ 0.1 is equivalent to a coverage≥ 90%). Once the template
is selected based on BATS results, MODELLER program is used
for the generation of 3D protein model. There is no significant
correlation statistically, between the number of templates used
during model building and the overall quality of a model. In the
next step, another MHOLline tool called FILTERS, categorizes
the BATS selected sequences (G2) into distinct quality model
subgroups, based on identity and LVI value. The subgroups
ranges Very High to Very Low. To evaluate the overall quality
and accuracy of the model, Ramachandran plot is obtained which
explained the stereochemical quality of the model. Precisely,
the MHOLine generates an aggregate structural information for
all the submitted sequences in the fasta format, Ramachandran
plot and other properties like structural quality and enzymatic
functions are also determined. Further details can be obtained by
2http://www.mholline.lncc.br
visiting MHOLline homepage (Hassan et al., 2014; Webb and Sali,
2016; Jamal et al., 2017a). For all modeled structures, structural
properties were figured as: (i) the Druggability Score (DS) for
each pocket and (ii) the active site residues (if available) according
to the template structures available at the protein databank RCSB-
PDB3 (Berman et al., 2003).
3D Protein Models in Non-reference
Strains: Orthologs Identification
We used an applied bioinformatics procedure to find the
conserved putative druggable targets across all the 13
C. diphtheriae strains at genome-scale by first predicting
their 3D models. The ensemble methodology essentially is a filter
of thousands of candidate genes to yield high-confidence 3D
structural models from orthologous proteins in C. diphtheriae
species. As aforementioned, the MHOLline resulted in 1,253
predicted structures for the randomly selected reference strain
NCTC13129 that were later used as template structures for
modeling the 3D structures in non-reference strains as well.
Further, the BLASTp program was installed in a local machine
and used to check if the ORFs of the reference proteome have
orthologs in the remaining 12 strains using the following
parameters; identity ≥ 85%, coverage > 80%. The protein
sequences showing high identity values (> = 85%) for each
reference and non-reference strain were considered as conserved
and the modeled structures of reference strain were used again
as templates to predict the 3D models for the aforementioned
12 non-reference strains. The core modelome was compared
and evaluated for the quality of the obtained 3D structures.
A reliable model has a probability of correct fold larger than
95% and coverage of over 50% with the template structure. For
each sequence in the reference and non-reference strain that
gave an identity hit of >85%, a mutation methodology was
applied on each amino acid substitution using the MODELLER
program. These models were then used to compute the
druggability variation for the 13 strains of the C. diphtheriae
species.
3www.wwpdb.org
Frontiers in Genetics | www.frontiersin.org 3 February 2018 | Volume 9 | Article 44
fgene-09-00044 February 12, 2018 Time: 17:2 # 4
Hassan et al. Druggable Pocketome of Corynebacterium diphtheriae; An in silico Approach
FIGURE 1 | Overview of pipeline components for data analysis.
Evaluation of Structural Druggability
The protein structural druggability of each predicted 3D model
was evaluated by determining the ability of putative pockets to
bind drug-like molecule/s, using the fpocket (Finn et al., 2016)
and the recently developed DrugScore (DS) programs (Velec
et al., 2005). The later methodology is based on the Voronoi
tessellation algorithm that identify and characterize pockets
and compute suitable physicochemical descriptors such as polar
and apolar surface area, hydrophobic-hydrophobic density and
polarity score. In conjunction they yield a druggability value that
ranges between 0 (non-druggable, ND) and 1 (highly druggable,
HD). We categorized the druggability scores for all predicted 3D
structures into four sets: non-druggable (ND; DS ≤ 0.2), poorly
druggable (PD; DS ≥ 0.2 and ≤0.5), druggable (D; DS ≥ 0.5 and
≤0.7), and highly druggable (HD; DS ≥ 0.7) protein pockets,
respectively. This distribution is in accordance to our previous
work where the druggability score was computed for all pockets
present in all unique proteins in the Protein Data Bank that
were experimentally crystallized in complex with a drug-like
compound/s (Radusky et al., 2014).
Identification of Active Site Residues
In order to identify the amino acid residues in the active site
of the predicted druggable protein pocket/s, information were
retrieved from the CSA database (Catalytic Site Atlas) (Furnham
et al., 2014) and Pfam position site (Finn et al., 2016), respectively.
A list of PDB_IDs was generated linked to a number of residues
constituting the corresponding protein active sites. To map the
active site residues to as many C. diphtheriae proteins as possible,
each PDB_ID was used as a template in CSA and assigned to the
modeled ORFs.
Host Homology, Essentiality, and
Core-Modelomics of the Selected
Targets
For off target prediction, the pool of global druggable (GD)
proteins was piped into NCBI-BLASTp using default parameters
(identity = 0% and/or no hit) against the human proteome to
identify non-host homologs. Moreover, from the filtered list of
10 highly druggable non-host homologous target proteins, an
approach based on subtractive genomics was implemented and
applied to the GD targets that were essential to bacteria (Barh
et al., 2011). Briefly, the set of target proteins of C. diphtheriae
was submitted to the Database of Essential Genes (DEG, which
contains experimentally validated essential genes from bacteria,
archaea and eukaryotes) for homology analyses (Zhang et al.,
2004). Again, we used BLASTp with E-value cut-off of 1e−05 a bit
score ≥ 100 and identity ≥ 35% (Barh et al., 2011). The final list
of putative targets based on criteria described earlier, contained
10 essential and non-host homologous target proteins. The
obtained list was further subjected to ProtParam4 for molecular
weight determination, biochemical pathway analysis to KEGG
(Kyoto Encyclopedia of Genes and Genomes) (Kanehisa and
Goto, 2000) using network enrichment (Alcaraz et al., 2012),
virulence using PAIDB (Pathogenicity Island Database) (Yoon
et al., 2007), functionality using UniProt (Universal Protein
Resource) (Magrane and UniProt, 2011), and cellular localization
using CELLO (subCELlular LOcalization predictor) (Yu et al.,
2004). In addition, we merged the final set of 10 selected
non-host homologous, essential and global druggable proteins
with results obtained through experiments locally performed in
our laboratories (Jamal et al., unpublished data) resulting in three
common targets, which we selected as candidates.
Protein–Protein Interaction Network
In biological systems, proteins work in a homogenous
environment rather than individual, hence it is important
to study protein–protein interactions (PPIs) for C. diphtheriae
metabolism. The identified drug targets were evaluated to
study their potential biological, functional and metabolic roles
for proteomic interactions. The selected drug targets were
used to develop intra-species protein–protein interactome
using STRING (Search Tool for the Retrieval of Interacting
4http://web.expasy.org/protparam/
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Genes/Proteins) database (Szklarczyk et al., 2015). STRING is an
online network analyses tool that provides essential information
regarding interactions of the desired proteins.
RESULTS AND DISCUSSION
Prediction of Structural Homology Based
Models
The complete modelome of the reference strain NCTC13129
was computed; consisting of 13,763 ORF, with 1,253 (∼9%)
resulting models. Taking the original models of reference strain
NCTC13129 as templates, we then generated 438 conserved
models in the 12 remaining strains using the MODELLER
software (Sali and Blundell, 1993). Afterward, the target-template
alignments have been computed using a BLAST E-value cut-
off of 10−6 in order to build the model structures using the
MODELLER software (Sali and Blundell, 1993; Webb and Sali,
2016). For each target-template alignment, ten different target
models were built, and their quality measures have been assessed
using GA341 (Melo and Feytmans, 1998; Melo and Sali, 2007)
and QMEAN (Benkert et al., 2009), keeping models with GA341
reliability scores ≥ 0.7 (Melo et al., 2002), leading to a final
set of 401 protein models. All these proteins are tabulated in
Supplementary Table S1.
Pocketome Druggability and Active Site
Residues of C. diphtheriae
The list of 401 targets protein drastically reduced to 137
after druggability analyses using the aforementioned fpocket
and the recently developed DS programs. A summary of only
highly druggable (HD) targets with drug score remained ≥ 0.7
were considered as global druggable. The calculated structural
druggability scores are given in Supplementary Table S2.
In Figure 2, a comparison of calculated druggability score
distribution across all structures of C. diphtheriae reference and
other strains is shown. Although the distribution has a small
shift to higher values, we used the same bounds to define the
sets of druggable proteins (Figure 2). A protein target, which
remained druggable in all strains, was classified as Globally
Druggable (GD).
Non-host Homology, Essentiality and
Core-Modelomics Analyses
As aforementioned, the list of 137 global druggable proteins
(Supplementary Table S2) was computed to the corresponding
human host proteome that resulted in the identification of
a very small set of only 10 non-host homologous proteins;
remaining 127 as host-homologous. The non-host homologous
targets were selected following a very stringent criterion, i.e.,
no identity, no hits. This list of final 10 essential and non-
host homologous targets in C. diphtheriae is given in Table 2.
We further report the involvement of these putative targets in
metabolic pathways, biological processes, cellular localization,
molecular weights and most importantly their potential role
as virulence factors. Out of 10 targets, 7 targets were found
as pathogen virulence factors using the PAIDB database based
on homology method. Further, we predicted the subcellular
localization of these final target proteins using support vector
machines, a methodology that is based on n-peptide composition
FIGURE 2 | Histogram of druggability score along the Corynebacterium diphtheriae reference/other strains. Representation of all ligand-bound structures in the PDB
(blue pointed line), all modeled structures of C. diphtheriae reference strain (red line, 1,253 models), and all modeled structures of the C. diphtheriae non-reference
genome strains (green line, 401 core proteins in 12 non-reference strains).
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of proteins, adapted in a related work by Yu et al. (2004), we
obtained three high-confidential candidates, which are; hisE,
glpX, and rpsH. Interestingly, these three high-confidential
candidates were identified as essential and non-host homologous
targets in our previous work by Jamal et al. (2017a). These
proteins were subjected to molecular docking analysis against
four different ligand libraries and a set of some potent molecules
were suggested for active inhibition of these proteins (Jamal et al.,
2017a).
hisE (Phosphoribosyl-ATP Pyrophosphatase)
hisE is the second enzyme in histidine-biosynthetic pathway
hydrolysing irreversibly phosphoribosyl-ATP to phosphoribosyl-
AMP and pyrophosphate. The protein is encoded by the hisE
gene, fused to hisI in many bacteria, fungi and plants but is
present as a separate gene in some bacteria and archaea. Since
it is seen in in vitro experiments that hisE is essential for
microorganism growth, we assume it a potential drug target
in C. diphtheriae. It is also reported as a drug candidate for
tuberculosis (Javid-Majd et al., 2008).
glpX (Fructose 1,6-Bisphosphatase II)
It is one of the main enzyme for gluconeogenesis that
catalyses the hydrolysis of fructose 1,6-bisphosphate to form
fructose 6-phosphate and orthophosphate. In glycolysis,
phosphofructokinase catalysis the reverse reaction, and the
product, fructose 6-phosphate, are important precursors
in various biosynthetic pathways (Horecker et al., 1975).
Gluconeogenesis is an important metabolic pathway in all
organisms and plays a key role by allowing the cells to synthesize
glucose from non-carbohydrate precursors, such as glycerol,
organic acids and amino acids. FBPases are members of lithium
sensitive phosphatases a large superfamily which includes three
families of inositol phosphatases and FBPases (phosphoesterase
clan CL0171, AA sequences 3167 from Pfam data base). They
are already reported as target for the treatment of non-insulin
dependent diabetes and development of new drugs (Wright et al.,
2002; Sassetti and Rubin, 2003).
rpsH (30S Ribosomal Protein S8)
The protein rpsH is one of the key RNA-binding protein having
a central position within the small ribosomal subunit. It interacts
widely with 16S rRNA and is fundamental for the correct folding
of the central domain of the ribosomal rRNA. Furthermore,
this protein regulates the synthesis of various other ribosomal
proteins by binding to mRNA. In the two RNA molecules, it binds
exactly to very similar sites. rpsH has a medium size and recently
it has been discovered that rpsH play vital role as a significant
primary RNA-binding protein in the 30S subunit. Mutations
in S8 within the protein are shown to result in defective
ribosomal assembly. The S8-binding site within 16S rRNA in
Escherichia coli, has been investigated independently by a number
of techniques including protein crosslinking, nuclease protection,
hydroxyl-radical foot printing, RNA–RNA modification and
chemical probing. The 30S ribosomal protein S8 is also one of
the principal regulatory elements that control ribosomal protein
synthesis by the translational feedback inhibition mechanism
discovered by Yates et al. (1980). It regulates the expression of
spc operon that encodes the 10 ribosomal proteins L5, L6, L14,
L15, L18, L24, L30, S5, S8, and S14, respectively (Davies et al.,
1996).
Protein–Protein Interaction Network for
Proposed Targets
Protein–protein interaction of target proteins with each
other have been constructed showing two proteins, rplJ
(VN94_02905/50S ribosomal protein L10) and rpsH (30S
ribosomal protein S8) to be interacting directly based on highest
confidence score 0.9. The confidence score is the approximate
probability that a predicted link exists between two enzymes in
the same metabolic map in the KEGG database. The evidences
for this interaction are gene fusion, co-occurrence, co-expression,
experimental and databases (Supplementary Figure S1).
CONCLUSION
We performed a comprehensive in silico study of the druggability
scores on all sequenced genomes of C. diphtheria resulting in
a list of intra-strain highly druggable pockets of 10 ORFs non-
homologous in human hosts. Previously, we have implemented
a similar approach using other bioinformatics tools for the
identification of putative therapeutic targets in C. diphtheriae
that relied primarily on the modelome construction followed by
filtering the obtained data for conserved targets (Jamal et al.,
2017a). In that work, a final set of eight essential and non-
host homologs targets were subjected to virtual screening using
different compound libraries but lacked a detailed overview of the
druggable protein pockets of the selected targets. Here, we further
extrapolated our work to the druggable pocketome at species level
and then at the end compared our final data set obtained in this
work with the aforementioned published data. The comparison
showed that any of the two approaches for putative targets
identification in pathogenic microorganisms might provide an
easy-to-handle protocol in future drug discovery projects. Our
pipeline is expandable and can be applied to other bacterial
species as well. In the future, we will work on Cytoscape plugins
to allow for mapping essential druggable non-homologous genes
to biological networks interactively for follow-up systems biology
investigation (Baumbach and Apeltsin, 2008). We believe that
our approach has the potential to aid in designing drugs
and/or vaccines, and in developing protein inhibitors as well as
discovering new lead compounds.
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